Eight institutions bid to be the new Centre of Excellence
Eight leading British universities and hospitals have been shortlisted in a stringent, peer-reviewed selection process to become the next Brain Tumour Research Centre of Excellence. The successful institution will enter a funding partnership with Brain Tumour Research, defining a new chapter in long-term research. The detailed analysis of the funding flows for brain tumours shows they still receive less than 1% of the national spend on cancer research, despite more children and adults under 40 dying of a brain tumour than any other cancer, and an increasing trend in diagnoses and deaths from this devastating disease.
Sue Farrington-Smith, Director of Brain Tumour Research says:
“Our unique national strategy means we will be providing 100% of our funds to support sustainable and continuous ground-breaking world class research at two Centres of Excellence from 2014.
The eight applicants include:
1. The Blizard Institute at Barts and the London School of Medicine, Queen Mary University of London, in collaboration with UCL Institute of Neurology
2. Imperial College Healthcare NHS Trust (London)
3. Centre for Cancer Research and Cell Biology at Queen’s University Belfast
4. Queen Elizabeth Hospital Birmingham and the University of Birmingham
5. The Walton Centre NHS Foundation Trust (Liverpool)
6. The University of Central Lancashire (UCLan)
7. Plymouth University Peninsula Schools of Medicine and Dentistry
8. Queen Elizabeth Hospital Birmingham, School of Cancer Sciences
Our vision is to establish seven such centres around the UK. We expect this process to result in closer ties with all these leading centres (and indeed other establishments that were interested but could not apply this time for various reasons) and unsuccessful applicants on this occasion will be encouraged to re-apply to be among our future centres.”